HSIC icon

Henry Schein

73.42 USD
-1.11
1.49%
At close Jul 11, 4:00 PM EDT
After hours
73.42
+0.00
0.00%
1 day
-1.49%
5 days
-0.96%
1 month
3.20%
3 months
13.90%
6 months
3.85%
Year to date
7.10%
1 year
12.78%
5 years
26.91%
10 years
27.78%
 

About: Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Employees: 25,000

0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

652% more call options, than puts

Call options by funds: $117M | Put options by funds: $15.6M

31% more first-time investments, than exits

New positions opened: 93 | Existing positions closed: 71

10% more funds holding in top 10

Funds holding in top 10: 10 [Q4 2024] → 11 (+1) [Q1 2025]

3% more funds holding

Funds holding: 536 [Q4 2024] → 551 (+15) [Q1 2025]

0.48% less ownership

Funds ownership: 102.63% [Q4 2024] → 102.14% (-0.48%) [Q1 2025]

2% less capital invested

Capital invested by funds: $8.86B [Q4 2024] → $8.68B (-$174M) [Q1 2025]

24% less repeat investments, than reductions

Existing positions increased: 160 | Existing positions reduced: 210

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$75
2%
upside
Avg. target
$79
8%
upside
High target
$86
17%
upside

4 analyst ratings

positive
50%
neutral
50%
negative
0%
Evercore ISI Group
Ross Muken
6%upside
$78
In-Line
Maintained
9 Jul 2025
Wells Fargo
Vik Chopra
2%upside
$75
Equal-Weight
Maintained
6 May 2025
Barrington Research
Michael Petusky
17%upside
$86
Outperform
Maintained
6 May 2025
Piper Sandler
Jason Bednar
5%upside
$77
Overweight
Maintained
30 Apr 2025

Financial journalist opinion

Based on 5 articles about HSIC published over the past 30 days

Positive
Zacks Investment Research
1 day ago
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term
Negative
Zacks Investment Research
4 days ago
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Investors are optimistic about HSIC, owing to the strong Henry Schein One performance. However, macro headwinds and fierce competition pose challenges.
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Positive
Zacks Investment Research
1 week ago
Henry Schein (HSIC) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Henry Schein (HSIC) is a Top-Ranked Value Stock: Should You Buy?
Positive
Zacks Investment Research
2 weeks ago
Henry Schein (HSIC) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Henry Schein (HSIC) is a Top-Ranked Growth Stock: Should You Buy?
Positive
Zacks Investment Research
4 weeks ago
Here's Why Henry Schein (HSIC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Henry Schein (HSIC) is a Strong Value Stock
Positive
Zacks Investment Research
1 month ago
Here's Why Henry Schein (HSIC) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Henry Schein (HSIC) is a Strong Growth Stock
Positive
Zacks Investment Research
1 month ago
Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue?
Neutral
Business Wire
1 month ago
Updated: Henry Schein to Participate in Upcoming Investor Conference in June
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, at 12:50 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be availab.
Updated: Henry Schein to Participate in Upcoming Investor Conference in June
Positive
Zacks Investment Research
1 month ago
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
Positive
Zacks Investment Research
1 month ago
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Investors are optimistic about HSIC, owing to the strong performance of its Henry Schein One business.
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Charts implemented using Lightweight Charts™